Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overview of pharmacogenomic testing in clinical practice
Tonya Gross, Jeremy Daniel
Mental Health Clinician (2018) Vol. 8, Iss. 5, pp. 235-241
Open Access | Times Cited: 23

Showing 23 citing articles:

Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis
Catherine R. Virelli, Ayeshah G. Mohiuddin, James L. Kennedy
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 43
Heterogeneity in the distribution of 159 drug-response related SNPs in world populations and their genetic relatedness
Tamim Ahsan, Nusrat Jahan Urmi, Abu Ashfaqur Sajib
PLoS ONE (2020) Vol. 15, Iss. 1, pp. e0228000-e0228000
Open Access | Times Cited: 27
Characterizing Pharmacogenetic Testing Among Children’s Hospitals
Jacob T. Brown, Laura B. Ramsey, Sara L. Van Driest, et al.
Clinical and Translational Science (2020) Vol. 14, Iss. 2, pp. 692-701
Open Access | Times Cited: 24
Pharmacogenetic Testing of Cytochrome P450 Drug Metabolizing Enzymes in a Case Series of Patients with Prader-Willi Syndrome
Janice L. Forster, Jessica Duis, Merlin G. Butler
Genes (2021) Vol. 12, Iss. 2, pp. 152-152
Open Access | Times Cited: 19
Physician Experience with Direct-To-Consumer Genetic Testing in Kaiser Permanente
M. Cabell Jonas, Pim Suwannarat, Andrea N. Burnett‐Hartman, et al.
Journal of Personalized Medicine (2019) Vol. 9, Iss. 4, pp. 47-47
Open Access | Times Cited: 22
Pharmacogenetic Testing: Why Is It So Disappointing?
Barbara J. Limandri
Journal of Psychosocial Nursing and Mental Health Services (2019) Vol. 57, Iss. 4, pp. 9-12
Closed Access | Times Cited: 18
Legal Challenges in Precision Medicine: What Duties Arising From Genetic and Genomic Testing Does a Physician Owe to Patients?
Scott McGrath, Arthur E. Peabody, D. Walton, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 16
An Overview of Pharmacogenomic Testing for Psychiatric Disorders
Calvin Young, Danielle MacDougall
Canadian Journal of Health Technologies (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 6
FHIR Lab Reports: using SMART on FHIR and CDS Hooks to increase the clinical utility of pharmacogenomic laboratory test results.
Michael T. Watkins, Karen Eilbeck
AMIA Summits on Translational Science proceedings (2020) Vol. 2020, pp. 683-692
Closed Access | Times Cited: 15
Pharmacogenomic Characterization in Bipolar Spectrum Disorders
Stefano Fortinguerra, Vincenzo Sorrenti, Pietro Giusti, et al.
Pharmaceutics (2019) Vol. 12, Iss. 1, pp. 13-13
Open Access | Times Cited: 15
PARC report: A Perspective on the state of Clinical Pharmacogenomics Testing
Jennifer N. Eichmeyer, Sara Rogers, Christine M. Formea, et al.
Pharmacogenomics (2020) Vol. 21, Iss. 11, pp. 809-820
Closed Access | Times Cited: 11
Rural Community Perceptions and Interests in Pharmacogenomics
John L. Stegelmeier, Christopher Nartker, C. Lowry Barnes, et al.
Healthcare (2020) Vol. 8, Iss. 2, pp. 159-159
Open Access | Times Cited: 10
Costing Methods as a Means to Measure the Costs of Pharmacogenomics Testing
Stavroula Siamoglou, Kariofyllis Karamperis, Christina Mitropoulou, et al.
The Journal of Applied Laboratory Medicine (2020) Vol. 5, Iss. 5, pp. 1005-1016
Open Access | Times Cited: 8
Perception and knowledge of pharmacogenetics among Brazilian psychiatrists
Beatriz Cantieri Almeida, Emanuella Dutra Gonçalves, Maria Helena de Sousa, et al.
Psychiatry Research (2021) Vol. 306, pp. 114238-114238
Closed Access | Times Cited: 4
Metabolic, genetic, and pharmacokinetic parameters for the prediction of olanzapine efficacy
Ling Cong, Zirui Wan, Pengfei Li, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 177, pp. 106277-106277
Open Access | Times Cited: 3
The Prevalence and Features of Medications With Actionable Pharmacogenomic Biomarkers Prescribed to Kidney Transplant Recipients
Yen-Lin Chang, Tzu‐Hung Hsiao, Mingfen Wu, et al.
Transplantation Proceedings (2023) Vol. 55, Iss. 4, pp. 862-866
Closed Access | Times Cited: 1
Maximizing patient safety when prescribing opioids for pain management
Megan Judy, D.A. Sams, Stephon Poulton
JAAPA (2023) Vol. 36, Iss. 9, pp. 1-6
Open Access | Times Cited: 1
Genetic Testing
Kariofyllis Karamperis, Sam Wadge, Maria Koromina, et al.
Elsevier eBooks (2019), pp. 189-207
Closed Access | Times Cited: 2
Genomic sequencing in severe epilepsy: a step closer to precision medicine
Mariagrazia Esposito, Ilaria Lagorio, Diego Peroni, et al.
Expert Review of Precision Medicine and Drug Development (2020) Vol. 5, Iss. 2, pp. 101-108
Closed Access | Times Cited: 1
Pharmacogenomic Testing for Mental Health (Part II): Qualitative Analysis of Early Adopter Prescriber Perceptions
Beatriz Manzor Mitrzyk, Melissa Plegue, Reema Kadri, et al.
Personalized Medicine (2021) Vol. 18, Iss. 3, pp. 233-240
Closed Access | Times Cited: 1
Pharmacogenomics in Older Adults: An Integrative Review
Ben R. Inventor, Olimpia Paun
Research in Gerontological Nursing (2021) Vol. 14, Iss. 4, pp. 211-220
Closed Access | Times Cited: 1
Part I: Interactive case—Precision medicine in psychiatry
Jonathan F. Lister, Kara R. Wong
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2023) Vol. 6, Iss. 3, pp. 307-311
Closed Access
Cytochrome P450
Mara Storto, Meera Balasubramaniam
Springer eBooks (2021), pp. 207-211
Closed Access
Page 1

Scroll to top